Cargando…

Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization

PURPOSE: To explore the in vivo anti-angiogenesis effects resulting from lentivirus-mediated RNAi of vascular endothelial growth factor (VEGF) in monkeys with iris neovascularization (INV). METHODS: Five specific recombinant lentiviral vectors for RNA interference, targeting Macaca mulatta VEGFA, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng-Ke, Tao, Yong, Yu, Wen-Zhen, Kai, Wang, Jiang, Yan-Rong
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927369/
https://www.ncbi.nlm.nih.gov/pubmed/20806089
_version_ 1782185745073569792
author Yuan, Meng-Ke
Tao, Yong
Yu, Wen-Zhen
Kai, Wang
Jiang, Yan-Rong
author_facet Yuan, Meng-Ke
Tao, Yong
Yu, Wen-Zhen
Kai, Wang
Jiang, Yan-Rong
author_sort Yuan, Meng-Ke
collection PubMed
description PURPOSE: To explore the in vivo anti-angiogenesis effects resulting from lentivirus-mediated RNAi of vascular endothelial growth factor (VEGF) in monkeys with iris neovascularization (INV). METHODS: Five specific recombinant lentiviral vectors for RNA interference, targeting Macaca mulatta VEGFA, were designed and the one with best knock down efficacy (LV-GFP-VEGFi1) in H1299 cells and RF/6A cells was selected by real-time PCR for in vivo use. A laser-induced retinal vein occlusion model was established in one eye of seven cynomolgus monkeys. In monkeys number1, 3, and 5 (Group 1), the virus (1×10(8) particles) was intravitreally injected into the preretinal space of the animal's eye immediately after laser coagulation; and in monkeys number 2, 4, and 6 (Group 2), the virus (1×10(8) particles) was injected at 10 days after laser coagulation. In monkey number 7, a blank control injection was performed. In monkeys number 1 and 2, virus without RNAi sequence was used; in monkeys number 3 and 4, virus with nonspecific RNAi sequence was used; and in monkeys 5 and 6, LV-GFP-VEGFi1 was used. RESULTS: In monkey number 5, at 23 days after laser treatment, no obvious INV was observed, while fluorescein angiography of the iris revealed high fluorescence at the margin of pupil and point posterior synechiae. At 50 days after laser treatment, only a slight ectropion uvea was found. However, in the other eyes, obvious INV or hyphema was observed. The densities of new iridic vessels all significantly varied: between monkey number 5 and number 3 (36.01±4.49/mm(2) versus 48.68±9.30/mm(2), p=0.025), between monkey number 3 and monkey number 7 (48.68±9.30/mm(2) versus 74.38±9.23/mm(2), p=0.002), and between monkey number 5 and number 7 (36.01±4.49/mm(2) versus 74.38±9.23/mm(2), p<0.001). CONCLUSIONS: Lentivirus-mediated RNAi of VEGF may be a new strategy to treat iris neovascularization, while further studies are needed to investigate the long-term effect.
format Text
id pubmed-2927369
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-29273692010-08-30 Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization Yuan, Meng-Ke Tao, Yong Yu, Wen-Zhen Kai, Wang Jiang, Yan-Rong Mol Vis Research Article PURPOSE: To explore the in vivo anti-angiogenesis effects resulting from lentivirus-mediated RNAi of vascular endothelial growth factor (VEGF) in monkeys with iris neovascularization (INV). METHODS: Five specific recombinant lentiviral vectors for RNA interference, targeting Macaca mulatta VEGFA, were designed and the one with best knock down efficacy (LV-GFP-VEGFi1) in H1299 cells and RF/6A cells was selected by real-time PCR for in vivo use. A laser-induced retinal vein occlusion model was established in one eye of seven cynomolgus monkeys. In monkeys number1, 3, and 5 (Group 1), the virus (1×10(8) particles) was intravitreally injected into the preretinal space of the animal's eye immediately after laser coagulation; and in monkeys number 2, 4, and 6 (Group 2), the virus (1×10(8) particles) was injected at 10 days after laser coagulation. In monkey number 7, a blank control injection was performed. In monkeys number 1 and 2, virus without RNAi sequence was used; in monkeys number 3 and 4, virus with nonspecific RNAi sequence was used; and in monkeys 5 and 6, LV-GFP-VEGFi1 was used. RESULTS: In monkey number 5, at 23 days after laser treatment, no obvious INV was observed, while fluorescein angiography of the iris revealed high fluorescence at the margin of pupil and point posterior synechiae. At 50 days after laser treatment, only a slight ectropion uvea was found. However, in the other eyes, obvious INV or hyphema was observed. The densities of new iridic vessels all significantly varied: between monkey number 5 and number 3 (36.01±4.49/mm(2) versus 48.68±9.30/mm(2), p=0.025), between monkey number 3 and monkey number 7 (48.68±9.30/mm(2) versus 74.38±9.23/mm(2), p=0.002), and between monkey number 5 and number 7 (36.01±4.49/mm(2) versus 74.38±9.23/mm(2), p<0.001). CONCLUSIONS: Lentivirus-mediated RNAi of VEGF may be a new strategy to treat iris neovascularization, while further studies are needed to investigate the long-term effect. Molecular Vision 2010-08-25 /pmc/articles/PMC2927369/ /pubmed/20806089 Text en Copyright © 2010 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yuan, Meng-Ke
Tao, Yong
Yu, Wen-Zhen
Kai, Wang
Jiang, Yan-Rong
Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
title Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
title_full Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
title_fullStr Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
title_full_unstemmed Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
title_short Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
title_sort lentivirus-mediated rna interference of vascular endothelial growth factor in monkey eyes with iris neovascularization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927369/
https://www.ncbi.nlm.nih.gov/pubmed/20806089
work_keys_str_mv AT yuanmengke lentivirusmediatedrnainterferenceofvascularendothelialgrowthfactorinmonkeyeyeswithirisneovascularization
AT taoyong lentivirusmediatedrnainterferenceofvascularendothelialgrowthfactorinmonkeyeyeswithirisneovascularization
AT yuwenzhen lentivirusmediatedrnainterferenceofvascularendothelialgrowthfactorinmonkeyeyeswithirisneovascularization
AT kaiwang lentivirusmediatedrnainterferenceofvascularendothelialgrowthfactorinmonkeyeyeswithirisneovascularization
AT jiangyanrong lentivirusmediatedrnainterferenceofvascularendothelialgrowthfactorinmonkeyeyeswithirisneovascularization